Watchlist Manager

Watchlist

Price: 6.77 CNY -0.88% Market Closed

Market Cap: ¥4.7B

Y	Yabao Pharmaceutical Group Co Ltd SSE:600351	CN
K	KPM Holding Ltd HKEX:8027	SG
	DLH Holdings Corp NASDAQ:DLHC	US
	Criteo SA NASDAQ:CRTO	FR
	Zhejiang Mustang Battery Co Ltd SSE:605378	CN
	NXP Semiconductors NV NASDAQ:NXPI	NL
K	KSG Agro SA WSE:KSG	UA
	Kushim Inc TSE:2345	JP
	Integra Lifesciences Holdings Corp NASDAQ:IART	US
	Sparebanken Vest OSE:SVEG	NO
V	VINX Corp TSE:3784	JP

Income Statement

Currency: CNY

	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	22	0	0	0	32	0	0	0	26	0	0	0	23	0	0	0	27	0	0	0	30	0	0	0	32	0	0	0	46	0	0	0	52	0	0	0	48	0	0	0	50	0	0	0	53	0	0	0	34	0	0	10	42	0	0	9	38	31	41	48	52	48	47	39	33	29	24	22	23	21	21	20	19	18	18	15	12	10	8	6	5	4	0	0
Revenue	597 N/A	619 +4%	656 +6%	655 0%	686 +5%	701 +2%	704 +0%	747 +6%	748 +0%	782 +5%	859 +10%	894 +4%	986 +10%	1 063 +8%	1 122 +6%	1 223 +9%	1 255 +3%	1 302 +4%	1 369 +5%	1 415 +3%	1 488 +5%	1 545 +4%	1 432 -7%	1 289 -10%	1 182 -8%	1 033 -13%	1 014 -2%	1 087 +7%	1 663 +53%	1 706 +3%	1 806 +6%	1 781 -1%	1 267 -29%	1 433 +13%	1 483 +3%	1 540 +4%	1 625 +6%	1 720 +6%	1 747 +2%	1 853 +6%	1 890 +2%	1 881 0%	2 012 +7%	2 086 +4%	2 066 -1%	2 083 +1%	1 903 -9%	1 777 -7%	1 806 +2%	1 811 +0%	2 060 +14%	2 325 +13%	2 559 +10%	2 768 +8%	2 822 +2%	2 955 +5%	2 918 -1%	2 970 +2%	3 049 +3%	3 009 -1%	3 042 +1%	2 844 -7%	2 621 -8%	2 567 -2%	2 602 +1%	2 772 +7%	2 915 +5%	2 957 +1%	2 764 -7%	2 665 -4%	2 593 -3%	2 531 -2%	2 718 +7%	2 824 +4%	2 957 +5%	2 945 0%	2 910 -1%	2 880 -1%	2 821 -2%	2 832 +0%	2 686 -5%	2 529 -6%	2 382 -6%	2 273 -5%
Gross Profit
Cost of Revenue	(389)	(405)	(428)	(422)	(449)	(463)	(471)	(497)	(489)	(502)	(558)	(584)	(653)	(718)	(754)	(836)	(848)	(876)	(906)	(924)	(978)	(1 008)	(891)	(757)	(643)	(499)	(499)	(522)	(968)	(1 004)	(1 058)	(1 062)	(620)	(737)	(782)	(801)	(887)	(904)	(882)	(931)	(898)	(892)	(964)	(1 004)	(981)	(1 036)	(1 006)	(988)	(1 008)	(1 048)	(1 094)	(1 141)	(1 116)	(1 185)	(1 210)	(1 290)	(1 167)	(1 220)	(1 182)	(1 099)	(1 126)	(1 065)	(1 013)	(1 031)	(1 066)	(1 173)	(1 212)	(1 241)	(1 087)	(1 076)	(1 107)	(1 094)	(1 211)	(1 285)	(1 328)	(1 319)	(1 237)	(1 267)	(1 265)	(1 335)	(1 317)	(1 284)	(1 211)	(1 126)
Gross Profit	208 N/A	215 +3%	228 +6%	234 +2%	237 +2%	238 +0%	232 -2%	249 +7%	259 +4%	280 +8%	301 +8%	310 +3%	333 +8%	344 +3%	367 +7%	386 +5%	407 +5%	426 +5%	463 +9%	491 +6%	510 +4%	537 +5%	541 +1%	532 -2%	539 +1%	534 -1%	516 -3%	565 +10%	694 +23%	701 +1%	748 +7%	718 -4%	646 -10%	696 +8%	701 +1%	739 +5%	738 0%	817 +11%	865 +6%	921 +7%	991 +8%	990 0%	1 049 +6%	1 083 +3%	1 085 +0%	1 047 -3%	897 -14%	789 -12%	798 +1%	763 -4%	966 +27%	1 183 +23%	1 442 +22%	1 583 +10%	1 612 +2%	1 665 +3%	1 751 +5%	1 750 0%	1 867 +7%	1 910 +2%	1 916 +0%	1 779 -7%	1 608 -10%	1 537 -4%	1 536 0%	1 599 +4%	1 704 +7%	1 716 +1%	1 677 -2%	1 589 -5%	1 486 -6%	1 437 -3%	1 507 +5%	1 539 +2%	1 629 +6%	1 626 0%	1 673 +3%	1 613 -4%	1 555 -4%	1 497 -4%	1 369 -8%	1 246 -9%	1 170 -6%	1 147 -2%
Operating Income
Operating Expenses	(145)	(148)	(165)	(173)	(181)	(185)	(185)	(198)	(211)	(222)	(230)	(231)	(246)	(243)	(253)	(268)	(276)	(290)	(305)	(314)	(332)	(339)	(347)	(349)	(358)	(360)	(383)	(408)	(423)	(444)	(457)	(474)	(508)	(541)	(557)	(578)	(610)	(669)	(679)	(696)	(763)	(745)	(796)	(809)	(824)	(788)	(744)	(766)	(829)	(830)	(914)	(1 040)	(1 172)	(1 293)	(1 305)	(1 322)	(1 388)	(1 362)	(1 465)	(1 518)	(1 540)	(1 708)	(1 626)	(1 594)	(1 383)	(1 431)	(1 519)	(1 508)	(1 469)	(1 365)	(1 285)	(1 287)	(1 312)	(1 361)	(1 414)	(1 370)	(1 356)	(1 375)	(1 305)	(1 225)	(1 045)	(953)	(871)	(885)
Selling, General & Administrative	(145)	(148)	(165)	(174)	(181)	(186)	(186)	(198)	(209)	(220)	(225)	(225)	(245)	(243)	(256)	(270)	(274)	(288)	(303)	(311)	(332)	(338)	(344)	(351)	(356)	(361)	(370)	(390)	(402)	(423)	(452)	(470)	(446)	(535)	(552)	(575)	(546)	(661)	(673)	(688)	(658)	(745)	(791)	(801)	(712)	(786)	(743)	(769)	(681)	(830)	(913)	(1 013)	(983)	(1 261)	(1 285)	(1 309)	(1 242)	(1 266)	(1 344)	(1 390)	(1 397)	(1 357)	(1 278)	(1 258)	(1 218)	(1 302)	(1 367)	(1 338)	(1 270)	(1 215)	(1 152)	(1 148)	(1 146)	(1 191)	(1 242)	(1 212)	(1 216)	(1 196)	(1 115)	(1 042)	(898)	(822)	(747)	(700)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(33)	0	0	0	(24)	0	0	0	(56)	0	0	0	(55)	0	0	0	(85)	0	0	(29)	(141)	0	0	(18)	(102)	(100)	(124)	(138)	(107)	(106)	(101)	(92)	(136)	(160)	(179)	(198)	(157)	(147)	(132)	(134)	(131)	(132)	(134)	(124)	(106)	(122)	(135)	(124)	(127)	(130)	(119)	(122)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(29)	0	0	0	(40)	0	0	0	(49)	0	0	0	(57)	0	0	0	(63)	0	0	0	(61)	0	0	0	(63)	0	0	0	(68)	0	0	0	(68)	0	0	0	(56)	0	0	0	(60)	0	0	0	(66)	0	0	0	(64)	0	0	0
Other Operating Expenses	0	1	1	1	0	0	1	0	(2)	(2)	(5)	(5)	(1)	1	2	2	(2)	(2)	(1)	(3)	(0)	(1)	(3)	2	(2)	1	(13)	(18)	(21)	(21)	(5)	(4)	(0)	(5)	(6)	(4)	(0)	(8)	(6)	(8)	(0)	0	(5)	(7)	(1)	(2)	(1)	3	(0)	0	(1)	1	13	(32)	(20)	4	19	4	4	10	32	(245)	(247)	(244)	39	31	26	28	14	(2)	(1)	(4)	25	(38)	(38)	(34)	33	(57)	(55)	(60)	44	(1)	(5)	(63)
Operating Income	63 N/A	67 +7%	64 -5%	61 -5%	56 -7%	53 -6%	48 -10%	52 +9%	48 -7%	58 +20%	71 +22%	79 +11%	87 +10%	102 +17%	114 +12%	119 +4%	131 +11%	136 +3%	158 +17%	177 +12%	178 +0%	198 +12%	195 -2%	183 -6%	181 -1%	174 -4%	133 -24%	158 +19%	271 +72%	258 -5%	291 +13%	244 -16%	138 -44%	156 +13%	144 -7%	160 +11%	128 -20%	148 +15%	186 +26%	225 +21%	228 +1%	245 +7%	252 +3%	274 +9%	261 -5%	259 -1%	153 -41%	23 -85%	(31) N/A	(67) -116%	52 N/A	143 +176%	270 +89%	290 +7%	307 +6%	343 +12%	363 +6%	388 +7%	403 +4%	392 -3%	376 -4%	71 -81%	(18) N/A	(57) -222%	153 N/A	168 +10%	185 +10%	208 +12%	207 0%	224 +8%	202 -10%	150 -25%	195 +30%	178 -9%	215 +21%	256 +19%	317 +24%	238 -25%	250 +5%	271 +9%	325 +20%	292 -10%	299 +2%	262 -12%
Pre-Tax Income
Interest Income Expense	(18)	(22)	(22)	(24)	(26)	(28)	(25)	(29)	(23)	(27)	(25)	(20)	(20)	(21)	(23)	(23)	(25)	(23)	(25)	(26)	(25)	(25)	(21)	(22)	(22)	(27)	(37)	(45)	(42)	(46)	(46)	(39)	(47)	(51)	(48)	(47)	(38)	(39)	(40)	(40)	(44)	(36)	(30)	(42)	(37)	(39)	(39)	(24)	(30)	(33)	(39)	(45)	(37)	(32)	(30)	(29)	(33)	(35)	(50)	(51)	(60)	(61)	(47)	(43)	(26)	(20)	(16)	(15)	(10)	(0)	9	10	(14)	(13)	(21)	(17)	(8)	(5)	(3)	(2)	(1)	(1)	0	2
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	57	57	57	57	(5)	1	0	0	1	0	0	0	(263)	3	3	2	(0)	0	0	0	6	0	0	0	(57)	1	1	1	(83)	0	0	0	(24)	0	0	0
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	(1)	0	0	0	(10)	0	0	0	2	0	0	(0)	23	(9)	(13)	(14)	(4)	(5)	(1)	(1)	(1)	(1)	56	56	(57)	(1)	(57)	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(3)	0	0	0
Total Other Income	(1)	(1)	(0)	(0)	0	1	1	(2)	(2)	(2)	(1)	2	1	1	1	5	5	5	7	5	2	4	5	4	4	2	(0)	1	23	15	15	17	36	36	50	67	16	46	36	12	10	16	16	23	25	24	26	31	88	31	19	(49)	(3)	(5)	(2)	(2)	(0)	(1)	(3)	(0)	(2)	(4)	(2)	(2)	1	0	(0)	(6)	(1)	(2)	(2)	3	3	3	3	2	(7)	(6)	(6)	(11)	(4)	(8)	(8)	(3)
Pre-Tax Income	44 N/A	44 +1%	41 -7%	36 -12%	30 -17%	27 -12%	24 -12%	22 -6%	24 +7%	29 +21%	45 +57%	61 +35%	68 +12%	82 +21%	92 +12%	100 +9%	111 +11%	118 +6%	140 +18%	156 +12%	156 0%	176 +13%	179 +2%	165 -8%	163 -1%	148 -9%	96 -35%	114 +19%	241 +111%	226 -6%	259 +15%	223 -14%	129 -42%	141 +9%	146 +4%	180 +23%	130 -28%	145 +11%	170 +17%	184 +8%	190 +3%	220 +16%	237 +8%	255 +7%	248 -3%	243 -2%	195 -20%	86 -56%	28 -68%	(13) N/A	33 N/A	107 +228%	225 +111%	252 +12%	275 +9%	312 +13%	330 +6%	352 +7%	350 0%	341 -3%	50 -85%	9 -82%	(64) N/A	(100) -56%	127 N/A	148 +16%	168 +13%	187 +11%	202 +8%	222 +10%	209 -6%	163 -22%	126 -23%	169 +34%	198 +17%	243 +23%	219 -10%	226 +3%	240 +6%	258 +7%	292 +13%	283 -3%	292 +3%	261 -10%
Net Income
Tax Provision	(16)	(16)	(17)	(15)	(13)	(13)	(11)	(10)	(8)	(9)	(15)	(18)	(13)	(23)	(20)	(18)	(25)	(20)	(27)	(32)	(28)	(32)	(30)	(26)	(23)	(22)	(15)	(19)	(44)	(41)	(47)	(42)	(19)	(22)	(24)	(26)	(17)	(18)	(27)	(38)	(25)	(31)	(22)	(20)	(30)	(26)	(17)	3	(1)	9	(5)	(17)	(25)	(32)	(31)	(34)	(46)	(48)	(51)	(49)	(39)	(35)	(25)	(24)	(18)	(15)	(21)	(23)	(18)	(32)	(25)	(17)	(21)	(26)	(25)	(33)	(39)	(45)	(52)	(62)	(68)	(63)	(68)	(68)
Income from Continuing Operations	28	28	25	22	17	14	13	12	16	19	30	42	55	60	72	83	87	98	113	124	128	144	150	138	139	126	81	95	197	185	213	181	110	119	123	154	113	127	142	146	165	189	215	234	218	217	178	89	27	(4)	27	90	200	220	244	278	284	304	300	292	11	(26)	(89)	(124)	109	133	147	164	184	190	185	146	105	143	173	210	180	181	189	196	224	220	224	194
Income to Minority Interest	2	3	5	6	8	8	8	10	8	8	3	(1)	(3)	(4)	(3)	(2)	(1)	(1)	(1)	0	1	2	2	3	5	6	8	7	(11)	(12)	(13)	(13)	2	3	4	4	5	6	5	6	5	4	4	3	4	6	(8)	(5)	(5)	(2)	13	12	0	(1)	(6)	(13)	(11)	(16)	(11)	(6)	3	5	4	3	(2)	(1)	(1)	(3)	3	4	4	3	0	(2)	(1)	2	20	23	23	25	19	17	13	29
Equity Earnings Affiliates	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	31 N/A	32 +4%	31 -5%	28 -8%	24 -13%	22 -12%	21 -1%	22 +3%	24 +7%	27 +14%	33 +22%	42 +27%	52 +26%	55 +5%	69 +26%	80 +16%	86 +6%	97 +13%	112 +16%	125 +11%	129 +4%	146 +13%	152 +4%	141 -7%	144 +2%	132 -8%	88 -33%	102 +15%	186 +83%	173 -7%	200 +15%	168 -16%	112 -33%	122 +8%	127 +4%	158 +25%	118 -25%	133 +12%	148 +11%	152 +3%	170 +12%	192 +13%	219 +14%	237 +9%	222 -6%	223 +1%	169 -24%	84 -50%	23 -73%	(7) N/A	40 N/A	102 +152%	200 +96%	220 +10%	238 +8%	265 +11%	273 +3%	289 +6%	288 0%	287 -1%	14 -95%	(21) N/A	(85) -299%	(121) -42%	107 N/A	132 +23%	146 +10%	161 +10%	187 +16%	194 +4%	188 -3%	149 -21%	105 -30%	141 +34%	172 +22%	212 +23%	200 -6%	204 +2%	211 +3%	221 +4%	243 +10%	238 -2%	237 0%	223 -6%
EPS (Diluted)	0.05 N/A	0.04 -20%	0.04 N/A	0.04 N/A	0.04 N/A	0.04 N/A	0.04 N/A	0.04 N/A	0.04 N/A	0.05 +25%	0.06 +20%	0.08 +33%	0.1 +25%	0.11 +10%	0.1 -9%	0.14 +40%	0.15 +7%	0.15 N/A	0.17 +13%	0.19 +12%	0.2 +5%	0.23 +15%	0.24 +4%	0.22 -8%	0.23 +5%	0.21 -9%	0.14 -33%	0.17 +21%	0.29 +71%	0.28 -3%	0.32 +14%	0.26 -19%	0.17 -35%	0.18 +6%	0.19 +6%	0.24 +26%	0.17 -29%	0.2 +18%	0.22 +10%	0.23 +5%	0.25 +9%	0.28 +12%	0.32 +14%	0.34 +6%	0.32 -6%	0.28 -12%	0.22 -21%	0.1 -55%	0.03 -70%	-0.02 N/A	0.04 N/A	0.12 +200%	0.25 +108%	0.28 +12%	0.31 +11%	0.35 +13%	0.35 N/A	0.38 +9%	0.38 N/A	0.38 N/A	0.02 -95%	-0.03 N/A	-0.11 -267%	-0.16 -45%	0.14 N/A	0.17 +21%	0.18 +6%	0.2 +11%	0.24 +20%	0.25 +4%	0.24 -4%	0.19 -21%	0.14 -26%	0.18 +29%	0.22 +22%	0.27 +23%	0.26 -4%	0.28 +8%	0.29 +4%	0.31 +7%	0.34 +10%	0.33 -3%	0.34 +3%	0.32 -6%

Income Statement Balance Sheet Cash Flow Statement

Yabao Pharmaceutical Group Co Ltd
SSE:600351

Income Statement

Earnings Waterfall
Yabao Pharmaceutical Group Co Ltd

Income Statement
Yabao Pharmaceutical Group Co Ltd

See Also

Company

Help

Tools

Stocks

Yabao Pharmaceutical Group Co Ltd SSE:600351

Income Statement

Earnings Waterfall Yabao Pharmaceutical Group Co Ltd

Income Statement Yabao Pharmaceutical Group Co Ltd

See Also

Company

Help

Tools

Stocks

Yabao Pharmaceutical Group Co Ltd
SSE:600351

Earnings Waterfall
Yabao Pharmaceutical Group Co Ltd

Income Statement
Yabao Pharmaceutical Group Co Ltd